BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Elekta and BrainLAB AG Collaborate to Enhance Radiosurgery Planning Power


10/8/2012 10:44:00 AM

STOCKHOLM and CHICAGO, Oct. 8, 2012 /PRNewswire/ -- At the opening of the 2012 Congress of Neurological Surgeons (CNS) Annual Meeting in Chicago, radiosurgery and neurosurgery innovators Elekta and Brainlab, announced a collaboration which will enable neurosurgeons and radiation oncologists to use Brainlab's iPlan® software together with Elekta's Leksell GammaPlan® treatment planning for Gamma Knife® radiosurgery.

Through the collaboration, clinicians will be given the option to add the functionality of iPlan RT Image to the optimized dosimetry and precision of Leksell GammaPlan treatment planning. iPlan, including multimodality image fusion, contouring, atlas-based auto segmentation, fiber tracking and BOLD fMRI analysis, brings additional tools to account for organs-at-risk and other important anatomical and functional structures in the brain.

University of California San Francisco (UCSF) is the first institution to use iPlan pre-planning functionality with Leksell GammaPlan. Andrew T. Parsa M.D., Ph.D., UCSF Professor and Vice Chairman of Neurological Surgery comments: "We are very excited at the possibility to complement our Gamma Knife radiosurgery treatment planning with advanced software features that have already provided an impact within our surgical environment."

Igor J. Barani, M.D., UCSF Clinical Research Director and Vice Chair, Department of Radiation Oncology, adds: "With the iPlan RT data enrichment enabled for GammaPlan, we get additional tools to optimize functional sparing and the best ablative treatment for tumors."

With more than 300 Leksell Gamma Knife systems in clinical use and more than 600,000 patients treated to date, Elekta is the world leader in intracranial radiosurgery, renowned for the precision and ease of use of the treatment planning and delivery system.

Commenting on the collaboration, Asa Hedin, Executive Vice President, Elekta Neuroscience says, "iPlan offers additional options to prepare data for treatment planning in GammaPlan. Many Gamma Knife users are already familiar with iPlan, and may now choose to also use the pre-planning tools in conjunction with Gamma Knife radiosurgery. In addition, this collaboration enables neurosurgeons who use Brainlab navigation to interact more easily with Gamma Knife radiosurgery."

Both Elekta and Brainlab will demonstrate the interface between iPlan pre-planning and Leksell GammaPlan treatment planning at the ongoing CNS meeting in Chicago.

For further information, please contact:
Johan Andersson Melbi, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

About Brainlab
Brainlab develops, manufactures and markets software-driven medical technology with the aim of optimizing patient treatments. Core products revolve around less-invasive image guided surgery technology, more accurate and effective radiation therapy, and integration through planning and collaboration systems that brings patient data and physicians together. www.brainlab.com.

SOURCE Elekta


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->